[#DIV28SUPER] FW: COVID-19 and SUD

Hi All,

 

Please see the link below regarding implications of the coronavirus for individuals with SUD:

https://www.drugabuse.gov/about-nida/noras-blog/2020/03/covid-19-potential-implications-individuals-substance-use-disorders

 

Thanks, Wendy

 

Wendy J. Lynch, Ph.D.

President, APA Division 28 (Psychopharmacology and Substance Abuse)

Associate Professor of Psychiatry and Neurobehavioral Sciences

Physical Address: 450 Ray C. Hunt Drive (Aurbach Building), Room G164

Mailing Address: PO Box 801402, Charlottesville, VA 22904-1402

434-243-0580 (office)

434-249-3699 (cell)

 

From: Aklin, Will (NIH/NIDA) [E] <aklinwm@nida.nih.gov>
Sent: Friday, March 13, 2020 3:53 PM
To: Lynch, Wendy J (wjl6w) <wjl6w@virginia.edu>
Subject: COVID-19 and SUD

 

Hi Wendy,

 

NIDA Director, Dr. Nora Volkow wrote a blog that was posted yesterday on the implications of Covid-19 for people with SUDs - https://www.drugabuse.gov/about-nida/noras-blog/2020/03/covid-19-potential-implications-individuals-substance-use-disorders This might be of particular interest to our Division.

 

Be well,

Will

 

--

Will M. Aklin, Ph.D.

Director, Behavioral Therapy Development Program (BTDP)

Clinical Research Grants Branch

Division of Therapeutics and Medical Consequences (DTMC)

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard, Rm. 4127, MSC 9593

Bethesda, MD 20892-9551

301-827-5909

aklinwm@mail.nih.gov